Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study - Concepedia

Concepedia

Publication | Open Access

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study

DOI Full Paper Access

77

Citations

59

References

2015

Year

Cheryl A. London, Heather L. Gardner, Tamra Mathie, N. Stingle, Roberta Portela, Michael L. Pennell, Craig A. Clifford, Mona P. Rosenberg, David M. Vail, Laurel E. Williams,

Abstract

The addition of toceranib to metronomic piroxicam/cyclophosphamide therapy following amputation and carboplatin chemotherapy did not improve median DFI, OS or the 1-year survival rate in dogs with OSA.

References

	Year	Citations

Page 1